トップページ > Surveillance of antibiotic sales in Japan (Archives)
Surveillance of antibiotic sales in Japan (Archives)
Surveillance of antibiotic sales in Japan
Updated on April 22, 2022
- Replaced with the latest version
- Data from 2013 to 2021 are available.
- Antibiotics are classified by category, route of administration, and the AWaRe Classification.
Details of the AWaRe Classification are as follows:
- Lists of the AWaRe Classification (Excel sheets)
- Defined daily dose (DDD), which is a measure of drug consumption, is according to data published on January 1, 2017.
Graphs and figures from the surveillance of antibiotic sales in Japan from 2013 to 2021
The population size was updated in 2021; thus, it was different from that published in February 2022.
Updated on April 13, 2021
- Replaced with the latest version
- Data from 2013 to 2020 are available.
- Antibiotics are classified by category, route of administration, and the AWaRe Classification.
Details of the AWaRe Classification are as follows:
- Defined daily dose (DDD), which is a measure of drug consumption, is according to data published on January 1, 2017.
Graphs and figures from the surveillance of antibiotic sales in Japan from 2013 to 2020
Updated on April 27, 2020
- Data from 2013 to 2019 are available.
- Antibiotics are classified by category, route of administration, and the AWaRe Classification.
Details of the AWaRe Classification are as follows:
- Defined daily dose (DDD), which is a measure of drug consumption, is according to data published on January 1, 2017.
Graphs and figures from the surveillance of antibiotic sales in Japan from 2013 to 2019